Biotechnology company using cell engineering to develop therapeutics for diseases of the female reproductive system
Gameto has raised €17M across 1 funding round from 9 investors, most recently a round in Sep 2022. Based in Madrid, Spain; active in Healthtech. Data as of 6 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-09-16 | Other | €17M |
| Arcadia Investment Partners,Bold Capital Partners,Future Ventures,Gaingels,Insight Partners,Korify Capital+3 more |
| View deal → |
